On the other hand, many reports have demonstrated that PKR is overexpressed and activated in several kinds of malignant diseases, such as acute myeloid leukemia, acute lymphoblastic leukemia, colon cancer, breast cancer, and lung cancer20–23. This evidence concerns the gene EIF2AK2 and acute myeloid leukemia.